Acute Disseminated Encephalomyelitis in Children and Adolescents: A Multicenter Retrospective Study of Relapse and

Seda Kanmaz1, Sanem Yılmaz1, Nihal Olgaç Dündar2

  • 1Faculty of Medicine, Department of Pediatric Neurology, Ege University, Izmir, Turkey.

PubMed

Insights

This study on acute disseminated encephalomyelitis found that anti-myelin oligodendrocyte glycoprotein antibody status did not impact relapse risk or recovery. Certain initial symptoms predict outcomes in pediatric ADEM patients.

Area of Science:

  • Pediatric Neurology
  • Neuroimmunology
  • Demyelinating Diseases

Background:

  • Acute disseminated encephalomyelitis (ADEM) is an immune-mediated inflammatory disease of the central nervous system.
  • Understanding factors influencing ADEM prognosis is crucial for patient management.
  • The role of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in ADEM outcomes requires further clarification.

Purpose of the Study:

  • To investigate demographic, clinical, laboratory, and prognostic data in children with ADEM.
  • To evaluate the association between anti-MOG antibody status and ADEM outcomes, including relapse and recovery.
  • To identify clinical predictors of relapse and incomplete recovery in pediatric ADEM.

Main Methods:

  • Retrospective analysis of 245 pediatric ADEM patients from 24 centers (2010-2022).
  • Assessment of short- and long-term outcomes: disease severity, course, clinical relapse, and recovery rates.
  • Univariant and multivariant analyses to determine predictors of outcome, with incomplete recovery defined as modified Rankin Score ≥1 or epilepsy.

Main Results:

  • ADEM typically presents in early childhood (mean age 6.3 years).
  • Relapse occurred in 12.6% of patients; predictors included sex, visual impairment, and ataxia.
  • Incomplete recovery (23.3%) was linked to seizures and ICU admission; anti-MOG positivity showed no association with relapse or incomplete recovery.

Conclusions:

  • The study supports the generally monophasic nature of ADEM with a high recovery rate in children.
  • Initial clinical presentation, including specific symptoms like seizures and ataxia, can help predict ADEM outcomes.
  • Anti-MOG antibody status does not appear to be a significant factor in ADEM relapse or recovery in this cohort.

Related Concept Videos

Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...